LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) will host a conference call for investors and other interested parties on Thursday, July 19, 2007 at 11:00 a.m. EST/8:00 a.m. PST to discuss recently announced plans for a Phase II clinical trial for the treatment of severe coronary heart disease. Company executives will also conduct a question and answer session following prepared remarks.
